ES8601301A1 - Un metodo para producir celulas cuyas respuestas inmunologicas humorales especificas de antigeno han sido moduladas. - Google Patents

Un metodo para producir celulas cuyas respuestas inmunologicas humorales especificas de antigeno han sido moduladas.

Info

Publication number
ES8601301A1
ES8601301A1 ES527138A ES527138A ES8601301A1 ES 8601301 A1 ES8601301 A1 ES 8601301A1 ES 527138 A ES527138 A ES 527138A ES 527138 A ES527138 A ES 527138A ES 8601301 A1 ES8601301 A1 ES 8601301A1
Authority
ES
Spain
Prior art keywords
medicament
manufacture
substituted guanine
aldose
cellular responses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES527138A
Other languages
English (en)
Spanish (es)
Other versions
ES527138A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Clinic and Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/439,846 external-priority patent/US4539205A/en
Application filed by Scripps Clinic and Research Foundation filed Critical Scripps Clinic and Research Foundation
Publication of ES527138A0 publication Critical patent/ES527138A0/es
Publication of ES8601301A1 publication Critical patent/ES8601301A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES527138A 1982-11-09 1983-11-08 Un metodo para producir celulas cuyas respuestas inmunologicas humorales especificas de antigeno han sido moduladas. Expired ES8601301A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/439,846 US4539205A (en) 1982-11-09 1982-11-09 Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US06/546,679 US4643992A (en) 1982-11-09 1983-11-01 Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives

Publications (2)

Publication Number Publication Date
ES527138A0 ES527138A0 (es) 1985-11-01
ES8601301A1 true ES8601301A1 (es) 1985-11-01

Family

ID=27032191

Family Applications (1)

Application Number Title Priority Date Filing Date
ES527138A Expired ES8601301A1 (es) 1982-11-09 1983-11-08 Un metodo para producir celulas cuyas respuestas inmunologicas humorales especificas de antigeno han sido moduladas.

Country Status (15)

Country Link
US (1) US4643992A (enExample)
EP (1) EP0112632B1 (enExample)
AU (1) AU568325B2 (enExample)
CA (1) CA1236401A (enExample)
DE (1) DE3382156D1 (enExample)
DK (1) DK167898B1 (enExample)
ES (1) ES8601301A1 (enExample)
FI (1) FI87733C (enExample)
GR (1) GR78733B (enExample)
IE (1) IE56701B1 (enExample)
IL (1) IL70164A (enExample)
NO (1) NO174215C (enExample)
NZ (1) NZ206208A (enExample)
PT (1) PT77636B (enExample)
WO (1) WO1984001898A1 (enExample)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849411A (en) * 1982-11-09 1989-07-18 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US5476659A (en) * 1982-11-09 1995-12-19 The Scripps Research Institute Cancerous B cell treatment using substituted nucleoside derivatives
US4900675A (en) * 1983-11-01 1990-02-13 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing isoxanthopterin-8-(1'-β-aldoglycosidyl) derivatives
US5093318A (en) * 1983-11-01 1992-03-03 Scripps Clinic And Research Foundation Immunostimulating guanosine derivatives and their pharmaceutical compositions
US5166141A (en) * 1983-11-01 1992-11-24 Scripps Clinic And Research Foundation Immunostimulating 7-deaza-7-oxa- and 7-deaza-7-oxo-analogs of 8-substituted-guanine-9-(1'-beta-D-aldoglycosidyl) derivatives and methods of treating test animals
FR2560212B1 (fr) * 1984-02-24 1989-12-29 Unicet Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
US5011828A (en) * 1985-11-15 1991-04-30 Michael Goodman Immunostimulating guanine derivatives, compositions and methods
ZA869297B (en) * 1985-12-13 1987-11-25 Scripps Clinic Res Modulation of animal cellular responses with compositions containing isoxanthopterin-8-(1'-beta-aldoglycosidyl)derivatives
US6060459A (en) * 1987-10-28 2000-05-09 Pro-Neuron, Inc. Enhancing blood cell count with oxypurine nucleosides
US4880784A (en) * 1987-12-21 1989-11-14 Brigham Young University Antiviral methods utilizing ribofuranosylthiazolo[4,5-d]pyrimdine derivatives
US4902985A (en) * 1988-02-25 1990-02-20 Raytheon Company Microwave reflectiion amplifiers having increased bandwidth
GB2216416B (en) * 1988-03-11 1992-06-24 Sandoz Ltd Nucleobase source for the stimulation of the immune system
WO1989010158A1 (en) * 1988-04-27 1989-11-02 Immunomedics, Inc. Improved radiotherapy
AU5845594A (en) * 1992-11-13 1994-06-08 Scripps Research Institute, The Cancerous b cell treatment using substituted nucleoside derivatives
US5786359A (en) * 1994-05-27 1998-07-28 The Scripps Research Institute N9 alkyl or aralkyl derivatives of 7, 8-disubstituted guanines
US5441942A (en) * 1994-05-27 1995-08-15 The Scripps Research Institute 2'3'-dideoxy-2',3'-didehydro-7,8-disubstituted guanosines and their immunostimulative effect
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
US20030100520A1 (en) * 1997-01-21 2003-05-29 Philip Needleman Immunological process and constructs for increasing the hdl cholesterol concentration by dna vaccination
US6303617B1 (en) 1998-05-04 2001-10-16 Neotherapeutics, Inc. Serotonin-like 9-substituted hypoxanthine and methods of use
US6562801B1 (en) * 1999-04-15 2003-05-13 Board Of Regents, The University Of Texas System PpGpp and pppGpp as immunomodulatory agents
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) * 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
DK1790344T3 (da) 2000-07-07 2011-05-02 Spectrum Pharmaceuticals Inc Fremgangsmåder til behandling af sygdomsfremkaldt perifer neuropati og beslægtede tilstande
US20030138769A1 (en) * 2000-08-16 2003-07-24 Birkett Ashley J. Immunogenic HBc chimer particles having enhanced stability
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
EP1395262A4 (en) * 2001-06-15 2006-04-12 Ribapharm Corp NUCLEOSIDE-VACCINE-ADJUVANTS
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
US7361352B2 (en) * 2001-08-15 2008-04-22 Acambis, Inc. Influenza immunogen and vaccine
US20030175863A1 (en) * 2001-08-15 2003-09-18 Birkett Ashley J. Influenza immunogen and vaccine
US7321033B2 (en) * 2001-11-27 2008-01-22 Anadys Pharmaceuticals, Inc. 3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
US7351413B2 (en) * 2002-02-21 2008-04-01 Lorantis, Limited Stabilized HBc chimer particles as immunogens for chronic hepatitis
ATE465742T1 (de) 2003-09-05 2010-05-15 Anadys Pharmaceuticals Inc Tlr7-liganden zur behandlung von hepatitis c
NZ555723A (en) 2004-12-17 2010-07-30 Anadys Pharmaceuticals Inc 3,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof
BRPI0618789A2 (pt) 2005-11-21 2016-08-30 Anadys Pharmaceuticals Inc processos de preparação de 5-amino-3h-tiazol [4,5-d] pirimidin-2-ona, de ciclocondensação de 2,4-diamino-5-halo-pirimidina e de oxidação de 5-amino-3h-tiazol [4,5-d] pirimidin-2-tiona
DE602007012247D1 (de) * 2006-06-22 2011-03-10 Anadys Pharmaceuticals Inc Prodrugs von 5-amino-3-(3'-deoxy-beta-d-ribofuranosyl)-thiazolä4,5-düpyrimidin-2,7-dion
DE602007012881D1 (en) 2006-07-18 2011-04-14 Anadys Pharmaceuticals Inc Carbonat- und carbamat-prodrugs von thiazolo ä4,5-dü-pyrimidinen
EP2173376B1 (en) * 2007-08-02 2015-03-25 Biondvax Pharmaceuticals Ltd. Multimeric multiepitope influenza vaccines
WO2009073179A2 (en) 2007-12-03 2009-06-11 President And Fellows Of Harvard College Chlamydia antigens
KR20110091560A (ko) 2008-12-03 2011-08-11 프로테아 벡신 테크놀로지스 엘티디. 글루타밀 ｔＲＮＡ 합성효소(ＧｔＳ) 단편들
SI2364314T1 (sl) 2008-12-09 2014-07-31 Gilead Sciences, Inc. Modulatorji Tollu podobnih receptorjev
WO2011067758A2 (en) 2009-12-02 2011-06-09 Protea Vaccine Technologies Ltd. Immunogenic fragments and multimers from streptococcus pneumoniae proteins
US9303070B2 (en) 2011-02-22 2016-04-05 Biondvax Pharmaceuticals Ltd. Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
WO2013150518A1 (en) 2012-04-01 2013-10-10 Rappaport Family Institute For Research In The Medical Sciences Extracellular matrix metalloproteinase inducer (emmprin) peptides and binding antibodies
AU2015242154B2 (en) 2014-04-03 2019-04-04 Biondvax Pharmaceuticals Ltd. Compositions of multimeric-multiepitope influenza polypeptides and their production
PT3166607T (pt) 2014-07-11 2022-12-07 Gilead Sciences Inc Moduladores de receptores de tipo toll para o tratamento do vih
SG11201701520TA (en) 2014-09-16 2017-04-27 Gilead Sciences Inc Solid forms of a toll-like receptor modulator

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1174077A (en) * 1967-02-18 1969-12-10 Ajinomoto Kk Process for Preparing 8-Mercaptopurine Derivatives

Also Published As

Publication number Publication date
IL70164A (en) 1988-06-30
WO1984001898A1 (en) 1984-05-24
DK334884D0 (da) 1984-07-06
NZ206208A (en) 1987-03-31
US4643992A (en) 1987-02-17
PT77636A (en) 1983-12-01
AU568325B2 (en) 1987-12-24
ES527138A0 (es) 1985-11-01
EP0112632B1 (en) 1991-02-06
AU2330284A (en) 1984-06-04
NO174215B (no) 1993-12-20
FI842748A0 (fi) 1984-07-09
IE832605L (en) 1984-05-09
IL70164A0 (en) 1984-02-29
NO842765L (no) 1984-07-06
FI842748L (fi) 1984-07-09
CA1236401A (en) 1988-05-10
PT77636B (en) 1986-03-19
NO174215C (no) 1994-03-30
FI87733B (fi) 1992-11-13
DE3382156D1 (de) 1991-03-14
EP0112632A3 (en) 1985-01-23
GR78733B (enExample) 1984-10-02
DK167898B1 (da) 1994-01-03
EP0112632A2 (en) 1984-07-04
IE56701B1 (en) 1991-11-06
FI87733C (fi) 1993-02-25
DK334884A (da) 1984-07-06

Similar Documents

Publication Publication Date Title
ES8601301A1 (es) Un metodo para producir celulas cuyas respuestas inmunologicas humorales especificas de antigeno han sido moduladas.
IE830227L (en) Pyrazolooxazines
DE3362784D1 (en) Process for preparing free-flowing ethylcellulose microcapsules
DE3267039D1 (en) Stable s-adenosylmethionine salts, the process for their preparation and therapeutic compositions which contain them as active principle
AU536920B2 (en) Hydroxypropyl-triazole derivatives and their use as antimycotic agents
ES8200094A1 (es) Procedimiento para la obtencion de alquilureas
ES8506704A1 (es) Un procedimiento para preparar derivados de aminoglicosido
ZA801483B (en) Peptides having ubiquitin-like activity
GR78106B (enExample)
ES482420A1 (es) Un procedimiento para la preparacion de 4-desoxi-4-acilamino-derivados de eritromicilamina.
AU8483382A (en) Amino cyclitol derivatives
ES8406468A1 (es) Procedimiento para la obtencion de derivados de terc.-butanol sustituidos
ES8103112A1 (es) Procedimiento para la obtencion de pseudo-trisacaridos
JPS54142194A (en) Manufacture of active carbon
ES467886A1 (es) Procedimiento para la preparacion de derivados de acido oleanoico.
FR2374319A1 (fr) Furanne- et thiophenecarbaldehydes substitues et furylalkylcetones substituees et thienylalkylcetones substituees, utiles notamment comme agents anti-rhinovirus, et leur procede de preparation
JPS5787073A (en) Protective active nitride as adding agent to non-aqueous positive electrode substance
GB1466411A (en) Sulphur-containing hydroxy aliphatic compounds
JPS51136277A (en) Lens for electron particle beam
ES8501734A1 (es) Un procedimiento para preparar derivados de cicloalquenilo
IL80928A0 (en) Method of modulation of animal cellular responses with compositions containing isoxanthopterin-8-(1'-beta-aldoglycosidyl)derivatives
ES484785A1 (es) Procedimiento para la obtencion de esteramidas de acido n- iso-propil-s.(1,6-dihidro-6(tio)oxo-pirimidazin(1)il-metil)-tiolfosforico, de accion plaguicida
JPS53118530A (en) Stabilization of synthetic oil for cosmetics
ES2004522A6 (es) Nuevo procedimiento para la preparacion de 4-(6' - metoxi-2'-naftil)butan-2-ona.
JPS53124544A (en) Adhesive composition having improved temperature stability

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050712